| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.34 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.099 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |